| Gram-negative neonatal sepsis in low-and lower-middle-income countries and WHO empirical antibiotic recommendations: A systematic review and meta-analysis SCH Wen, Y Ezure, L Rolley, G Spurling, CL Lau, S Riaz, DL Paterson, ... PLoS medicine 18 (9), e1003787, 2021 | 69 | 2021 |
| Cutibacterium acnes in shoulder surgery: a scoping review of strategies for prevention, diagnosis, and treatment AL Foster, K Cutbush, Y Ezure, MA Schuetz, R Crawford, DL Paterson Journal of Shoulder and Elbow Surgery 30 (6), 1410-1422, 2021 | 33 | 2021 |
| Is Ceftazidime/Avibactam an Option for Serious Infections Due to Extended-Spectrum-β-Lactamase- and AmpC-Producing Enterobacterales?: a Systematic Review … B Isler, Y Ezure, JLGF Romero, P Harris, AG Stewart, DL Paterson Antimicrobial agents and chemotherapy 65 (1), 10.1128/aac. 01052-20, 2020 | 28 | 2020 |
| Adverse clinical outcomes associated with infections by Enterobacterales producing ESBL (ESBL-E): a systematic review and meta-analysis W Ling, L Furuya-Kanamori, Y Ezure, PNA Harris, DL Paterson JAC-antimicrobial Resistance 3 (2), dlab068, 2021 | 21 | 2021 |
| Efficacy and safety of carbapenems vs new antibiotics for treatment of adult patients with complicated urinary tract infections: a systematic review and meta-analysis Y Ezure, V Rico, DL Paterson, L Hall, PNA Harris, A Soriano, JA Roberts, ... Open Forum Infectious Diseases 9 (5), ofaa480, 2022 | 11 | 2022 |
| Adverse clinical outcomes associated with carbapenem-resistant Acinetobacter (CRA) infections: a systematic review and meta-analysis W Ling, L Furuya-Kanamori, Y Ezure, PNA Harris, DL Paterson JAC-Antimicrobial Resistance 3 (4), dlab157, 2021 | 5 | 2021 |
| In vitro, in vivo and clinical studies comparing the efficacy of ceftazidime-avibactam monotherapy with ceftazidime-avibactam-containing combination regimens against carbapenem … AT Aslan, Y Ezure, JP Horcajada, PNA Harris, DL Paterson Frontiers in Medicine 10, 2023 | 4 | 2023 |
| Pediatric Central Venous Access Device Lock Solutions: A Network Meta-analysis M Takashima, Y Ezure, L Furuya-Kanamori, J Wolf, M Dufficy, V Gibson, ... Pediatrics 153 (2), e2023063264, 2024 | 1 | 2024 |
| Is ceftazidime/avibactam an option for serious infections due to ESBL and AmpC producing Enterobacterales?: a systematic review and meta-analysis B Isler, Y Ezure, JL García-Fogeda Romero, P Harris, AG Stewart, ... Antimicrobial Agents and Chemotherapy 65 (1), 2020 | 1 | 2020 |
| Methodological Progress Note: Choosing analytic methods for randomized trials MD Takashima, Y Ezure, AJ Ullman, RS Ware Journal of Hospital Medicine, 2024 | | 2024 |
| Scoping review of risk-scoring tools for early prediction of bloodstream infections caused by carbapenem-resistant Enterobacterales: do we really have a reliable risk-scoring tool? AT Aslan, Y Ezure, PNA Harris, DL Paterson JAC-Antimicrobial Resistance 6 (1), dlae032, 2024 | | 2024 |
| Gram-Negative Neonatal Sepsis in Low-and Middle-Income Countries: How Appropriate are the WHO Recommended Empirical Sepsis Antibiotic Regimens? A Systematic Review and Meta … SCH Wen, Y Ezure, L Rolley, G Spurling, CL Lau, DL Paterson, AD Irwin A Systematic Review and Meta-Analysis, 2021 | | 2021 |
